SCHEMBL4066409

SCHEMBL4066409

O=CC[C@H](OP(O)(O)=S)[C@H](O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL139867 0.83 PTPN1 (0.38)
SCHEMBL6429913 0.83 PTPN1 (0.38)
SCHEMBL6045219 0.83
SCHEMBL6045389 0.80 MPI (0.31)
SCHEMBL7104411 0.77 BTN3A1 (0.39)
SCHEMBL10380111 0.77 PTPN1 (0.32)
Water SCHEMBL7160933 0.76 LPAR6 (0.30)
SCHEMBL320909 0.75 BTN3A1 (0.37)
SCHEMBL27743391 0.74 AKR1B1 (0.33)
SCHEMBL199123 0.74 AKR1B1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008116165-A9 METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION NEXT SAFETY INC (US) 2009-06-11 WO claimed
WO-2008116165-A2 METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION NEXT SAFETY, INC. (US) 2008-09-25 WO claimed
US-20080066741-A1 METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION HUNTER, CHARLES ERIC 2008-03-20 US claimed
US-20060183886-A1 Ligands to enhance cellular uptake of biomolecules CELL WORKS THERAPEUTICS, INC., A DELAWARE CORPORATION 2006-08-17 US claimed
EP-1409548-A4 LIGANDS TO ENHANCE CELLULAR UPTAKE OF BIOMOLECULES CELL WORKS THERAPEUTICS INC (US) 2005-08-31 EP claimed
EP-1409548-A2 LIGANDS TO ENHANCE CELLULAR UPTAKE OF BIOMOLECULES Cell Works Inc. (US) 2004-04-21 EP claimed
WO-2003067209-A2 LIGANDS TO ENHANCE CELLULAR UPTAKE OF BIOMOLECULES CELL WORKS INC. (US) 2003-08-14 WO claimed
US-20030119724-A1 Ligands to enhance cellular uptake of biomolecules NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-06-26 US claimed
US-20240123168-A1 PRODUCT DELIVERY DEVICES AND METHODS MUSTAPHA JIHAD A (US) 2024-04-18 US disclosed
EP-4255541-A1 PRODUCT DELIVERY DEVICES AND METHODS Breathe Restore, Inc. (US) 2023-10-11 EP disclosed
US-20230181847-A1 PRODUCT DELIVERY DEVICES AND METHODS BREATHE RESTORE INC (US) 2023-06-15 US disclosed
US-11672929-B2 Product delivery devices and methods BREATHE RESTORE, INC. (US) 2023-06-13 US disclosed
WO-2022118225-A1 PRODUCT DELIVERY DEVICES AND METHODS BREATHE RESTORE, INC. (US) 2022-06-09 WO disclosed
US-20220168516-A1 PRODUCT DELIVERY DEVICES AND METHODS BREATHE RESTORE, INC. 2022-06-02 US disclosed
US-9554989-B2 Silk reservoirs for drug delivery TRUSTEES OF TUFTS COLLEGE (US) 2017-01-31 US disclosed
US-20150065685-A1 LASER-ACTUATED THERAPEUTIC NANOPARTICLES PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2015-03-05 US disclosed
US-20150045764-A1 SILK RESERVOIRS FOR DRUG DELIVERY TRUSTEES OF TUFTS COLLEGE 2015-02-12 US disclosed
EP-2827884-A1 SILK RESERVOIRS FOR DRUG DELIVERY Trustees Of Tufts College (US) 2015-01-28 EP disclosed
WO-2013148158-A1 LASER-ACTUATED THERAPEUTIC NANOPARTICLES PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2013-10-03 WO disclosed
WO-2013142119-A1 SILK RESERVOIRS FOR DRUG DELIVERY TRUSTEES OF TUFTS COLLEGE (US) 2013-09-26 WO disclosed